Analysguiden uppdaterar investeringscaset i Coor. En marknadsledare med stabil historik vars aktie e...
Redeye briefly comments on NeoDynamics’ rights issue.
Redeye is encouraged to see that OXE Marine has received another order from the US Defense Logistics...
Redeye retains its positive view of Transtema despite lowering our forecasts and Base Case.
Över 64 miljoner patienter lider av hjärtsvikt världen över och varje år uppgår dödssiffran till omk...
Redeye takes a positive view regarding the entrance of Alta Fox, a respected US-based investment fir...
Redeye updates its view on Beyond Frames following its recent successful game releases (through its ...
DT has successfully navigated through external obstacles and now has a prime opportunity to concentr...
AAC Clyde Space has announced a rights issue to raise SEK73.
Redeye initiates coverage of Pagero, a software-as-a-service (SaaS) company that helps businesses si...
Redeye view yesterdays announcement of a cost cutting program as a sign that the market is developin...
Redeye comments on Scandinavian ChemoTech’s latest supplier contract with MedVet Group and the initi...
Redeye comments on the positive readout from the phase I/IIa trial with the anti-TNFR2 antibody BI-1...
Marknadsledare i fragmenterad marknad BTS utvecklar och levererar program för förändringsarbete och ...
Redeye comments on the new patent application for partial degradation and purification of PFAS in wa...
Q4 highlights that Biovica has secured two contracts with Contigo Health and MedIncrease, access to ...
Redeye comments on Better Collective’s upgraded financial targets for 2023E which the company has in...
SEK 266m directed share issue: ~15% disc., ~14% dilution New institutional backing helps mitigate fu...
SEK 875m directed share issue Proforma deleveraging from ~3.
We expect high inventories at retailers to have continued burdening Fiskars' sales in Q2.
